Effects of Pioglitazone on Asymmetric Dimethylarginine and Components of the Metabolic Syndrome in Nondiabetic Patients (EPICAMP Study): A Double-Blind, Randomized Clinical Trial

The present trial aimed to investigate the effects of pioglitazone on the serum level of asymmetric dimethylarginine (ADMA), a marker of endothelial function, and some indices of inflammation and glucose and lipid metabolism in nondiabetic metabolic syndrome patients. 104 eligible participants (57%...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokouh, Pedram, Joharimoghadam, Adel, Roohafza, Hamidreza, Sadeghi, Masoumeh, Golabchi, Allahyar, Boshtam, Maryam, Sarrafzadegan, Nizal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654334/
https://www.ncbi.nlm.nih.gov/pubmed/23710164
http://dx.doi.org/10.1155/2013/358074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654334/
https://www.ncbi.nlm.nih.gov/pubmed/23710164
http://dx.doi.org/10.1155/2013/358074

Ejemplares similares